Fig. 5: CBD-SA-IL-4 (100 µg/ mL IL-4 equivalent) does not show toxicity after a single subcutaneous administration. | npj Regenerative Medicine

Fig. 5: CBD-SA-IL-4 (100 µg/ mL IL-4 equivalent) does not show toxicity after a single subcutaneous administration.

From: Topically-applied collagen-binding serum albumin-fused interleukin-4 modulates wound microenvironment in non-healing wounds

Fig. 5: CBD-SA-IL-4 (100 µg/ mL IL-4 equivalent) does not show toxicity after a single subcutaneous administration.The alternative text for this image may have been generated using AI.

a Percent change in body weight over four-day time course. b Serum triglyceride levels two days post treatment. c Serum albumin levels two days post treatment. d Serum alkaline phosphatase level two days post treatment. e Serum blood urea nitrogen (BUN) levels two days post treatment. f serum total bilirubin (TBILI) levels two days post treatment. g Serum creatinine (CREAT) levels two days post treatment. h B Cells (B220+) in blood two days post treatment. i Spleen wet weight four days post-treatment. Statistics: Ordinary one-way ANOVA with Tukey multiple comparisons test was used. *p < 0.05, **p < 0.01, ***p < 0.001 (all groups n = 6; mean ± SEM).

Back to article page